Back

The protective effect of beta-blockers in 3,278 advanced heart failure patients treated with continuous inotropes

26 May 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 3 - Chronic Heart Failure – Treatment Treatment HFA Premium Access Heart Failure 2018

About the speaker

Photo
Associate Professor Ofer Havakuk

Tel Aviv Sourasky Medical Center, Tel Aviv (Israel)

38 More presentations in this session

Presentation thumbnail
Tertiary heart failure care in the netherlands: what is the added value
Miss M. Vester (Leiden, NL)
Abstract Slides
Presentation thumbnail
The benefits of ivabradine in the management of angina pectoris and heart failure.
Professor Z. RAISSUNI (Tanger, MA)
Abstract
Presentation thumbnail
Anti diabetic therapy in patients with heart failure and type 2 diabetes mellitus in general population.
Presentation thumbnail
The association between adherence to evidence-based medicines and outcomes in seniors with heart failure: a landmark analysis
Presentation thumbnail
Sacubitril/valsartan improves functional class and objective parameters in heart failure patients with reduced ejection fraction and its discontinuation is associated with a poor prognosis.
Doctor L. Vicent Alaminos (Madrid, ES)
Abstract

Access the full session

Session thumbnail
Poster Session 3 - Chronic Heart Failure – Treatment

The Event

Event poster

Heart Failure 2018

26 May - 29 May 2018
You may be interested in
thumbnail
Congress Presentation
The role of ICD therapy in heart failure in 2024. What is the holistic approach to treat heart failure?
thumbnail
Congress Presentation
Breaking the barriers in guideline-directed medical therapy implementation in heart failure - discussion
thumbnail
Congress Presentation
Expert panel discussion and Q&A

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources